Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
F P KroonR van Furth

Abstract

A prospective study of antibody production by adults infected with human immunodeficiency virus (HIV) after vaccination with T lymphocyte-dependent diphtheria toxoid, tetanus toxoid, and inactivated trivalent poliovirus vaccine was conducted. Individuals were divided into three groups according to CD4+ T-lymphocyte count: group 1 had a count of < or = 100-300 x 10(6)/L; and group 3, > 300 x 10(6)/L. After vaccination, 61%, 70%, and 73% of the individuals in groups 1, 2, and 3, respectively, developed protective titers of antibody to diphtheria toxin; the mean postvaccination antibody titer of HIV-infected individuals was significantly lower than that of healthy controls not infected with HIV. Furthermore, the mean titers of antibodies to tetanus toxin and poliovirus were significantly lower in HIV-infected individuals with CD4+ lymphocyte counts of < 300 x 10(6)/L than in controls. Of the HIV-infected vaccinees, 83%-100% were protected against tetanus and 78%-100% against polio. We conclude that HIV-infected individuals with CD4+ lymphocyte counts of < 300 x 10(6)/L have an impaired (secondary) antibody response after receipt of T lymphocyte-dependent vaccines.

Citations

Sep 22, 2007·Current HIV/AIDS Reports·Edgar Turner Overton
Nov 30, 2000·Current Infectious Disease Reports·S A Tasker, M R Wallace
Mar 10, 2006·Current Infectious Disease Reports·Todd D GleesonSybil A Tasker
Oct 25, 2003·Journal of the American Academy of Dermatology·Alice B GottliebKenneth B Gordon
Mar 17, 2004·Viral Immunology·Beth C MarshallUNKNOWN Studies Of Ocular Complications Of AIDS Research Group
Mar 1, 1997·The Pediatric Infectious Disease Journal·E VidorS Plotkin
May 1, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·S BaroncelliS P Mendoza
Dec 8, 2011·The Pediatric Infectious Disease Journal·Devasena GnanashanmugamYvonne A Maldonado
Apr 7, 2007·AIDS·David R Chadwick, Anna Maria Geretti
Nov 21, 2007·AIDS·Philippe LespritUNKNOWN ANRS 114-Pneumovac Study Group
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·J J FarrarC M Parry
May 21, 2010·BMC Research Notes·Alexandre ManirakizaIonela Gouandjika-Vasilache
Dec 7, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lorry G Rubin Infectious Diseases Society of America
Jul 17, 2014·AIDS Patient Care and STDs·Nancy F Crum-Cianflone, Mark R Wallace
Aug 30, 2008·Médecine et maladies infectieuses·C CouzigouD Vittecoq
Nov 26, 2015·British Medical Bulletin·C L Thwaites, H T Loan
Oct 19, 2007·La Revue de médecine interne·P Duchet NiedziolkaUNKNOWN pour le groupe GEVACCIM
Mar 3, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·R John LooneyUNKNOWN Autoimmunity Centers of Excellence Immunocompetency Committee
Apr 16, 2008·Clinical and Experimental Immunology·C T BurtonUNKNOWN INITIO Trial International Co-ordinating Committee
Aug 19, 2004·Vaccine·Tatiana C S BonettiM Isabel de Moraes-Pinto
May 10, 2006·Biologicals : Journal of the International Association of Biological Standardization·Edwin J AsturiasNeal A Halsey
Jul 11, 1998·Infectious Disease Clinics of North America·M D Mileno, F J Bia
Oct 22, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Shahana A Choudhury, Fazle Matin
Feb 11, 2015·The Journal of the Association of Nurses in AIDS Care : JANAC·Patricia A CioeJerome Larkin
Aug 30, 2016·HIV Medicine·Anna Maria GerettiAlison Rodger
Jun 15, 2005·Expert Opinion on Pharmacotherapy·Matthias L CavassiniPhilip E Tarr
Aug 7, 2017·Infectious Diseases and Therapy·Nancy F Crum-Cianflone, Eva Sullivan
Feb 1, 2003·Transfusion·Fouad N BoctorJoan Uehlinger
Aug 6, 2017·Infectious Diseases and Therapy·Nancy F Crum-Cianflone, Eva Sullivan
May 9, 2019·Journal of Travel Medicine·Lisa ChangJoseph Torresi
Mar 10, 2021·Infectious Diseases and Therapy·Elda RighiEvelina Tacconelli
Jun 22, 2021·The Lancet. HIV·Matthew A Spinelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.